Exhibit 99.1
 |
KPMG
LLP L4K 0J3 |
Fax (905) 265-6390 |
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Aptose Biosciences Inc.
We consent to the incorporation by reference in the registration statement on Form F-3 (333-200660) and in the registration statement on Form S-8 (No. 333-205158), each of Aptose Biosciences Inc., of our report dated March 28, 2017 on the consolidated statement of financial position of Aptose Biosciences Inc. as of December 31, 2016 and 2015, and the related consolidated statements of loss and comprehensive loss, changes in shareholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2016 and the seven-month period ended December 31, 2014, and notes, comprising a summary of significant accounting policies and other explanatory information, which report appears in the annual report on Form 20-F of Aptose Biosciences Inc. for the year ended December 31, 2016.
Chartered Accountants, Licensed Public Accountant
Toronto, Canada
March 28, 2017
KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. KPMG Canada provides services to KPMG LLP. |